United States Biologics and Biosimilars Market Report 2016

Publisher Name :
Date: 17-Oct-2016
No. of pages: 120
Inquire Before Buying

Notes:

Sales, means the sales volume of Biologics and Biosimilars

Revenue, means the sales value of Biologics and Biosimilars

This report studies sales (consumption) of Biologics and Biosimilars in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Pfizer

- Roche

- Amgen

- AbbVie

- Sanofi

- Johnson & Johnson

- Novo Nordisk

- Novartis

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Biologics

- Biosimilars

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Biologics and Biosimilars in each application, can be divided into

- Tumor

- Diabetes

- Cardiovascular

- Others

United States Biologics and Biosimilars Market Report 2016

Table of Contents
United States Biologics and Biosimilars Market Report 2016
1 Biologics and Biosimilars Overview
1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Classification of Biologics and Biosimilars
1.2.1 Biologics
1.2.2 Biosimilars
1.2.3 Type III
1.3 Application of Biologics and Biosimilars
1.3.1 Tumor
1.3.2 Diabetes
1.3.3 Cardiovascular
1.3.4 Others
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Biologics and Biosimilars (2011-2021)
1.4.1 United States Biologics and Biosimilars Sales and Growth Rate (2011-2021)
1.4.2 United States Biologics and Biosimilars Revenue and Growth Rate (2011-2021)
2 United States Biologics and Biosimilars Competition by Manufacturers
2.1 United States Biologics and Biosimilars Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Biologics and Biosimilars Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Biologics and Biosimilars Average Price by Manufactures (2015 and 2016)
2.4 Biologics and Biosimilars Market Competitive Situation and Trends
2.4.1 Biologics and Biosimilars Market Concentration Rate
2.4.2 Biologics and Biosimilars Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Biologics and Biosimilars Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Biologics and Biosimilars Sales and Market Share by Type (2011-2016)
3.2 United States Biologics and Biosimilars Revenue and Market Share by Type (2011-2016)
3.3 United States Biologics and Biosimilars Price by Type (2011-2016)
3.4 United States Biologics and Biosimilars Sales Growth Rate by Type (2011-2016)
4 United States Biologics and Biosimilars Sales (Volume) by Application (2011-2016)
4.1 United States Biologics and Biosimilars Sales and Market Share by Application (2011-2016)
4.2 United States Biologics and Biosimilars Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Biologics and Biosimilars Manufacturers Profiles/Analysis
5.1 Pfizer
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Biologics and Biosimilars Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Roche
5.2.2 Biologics and Biosimilars Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Amgen
5.3.2 Biologics and Biosimilars Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 AbbVie
5.4.2 Biologics and Biosimilars Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Sanofi
5.5.2 Biologics and Biosimilars Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Sanofi Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Johnson & Johnson
5.6.2 Biologics and Biosimilars Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Novo Nordisk
5.7.2 Biologics and Biosimilars Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Novartis
5.8.2 Biologics and Biosimilars Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
6 Biologics and Biosimilars Manufacturing Cost Analysis
6.1 Biologics and Biosimilars Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Biologics and Biosimilars
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Biologics and Biosimilars Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Biologics and Biosimilars Market Forecast (2016-2021)
10.1 United States Biologics and Biosimilars Sales, Revenue Forecast (2016-2021)
10.2 United States Biologics and Biosimilars Sales Forecast by Type (2016-2021)
10.3 United States Biologics and Biosimilars Sales Forecast by Application (2016-2021)
10.4 Biologics and Biosimilars Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Biologics and Biosimilars
Table Classification of Biologics and Biosimilars
Figure United States Sales Market Share of Biologics and Biosimilars by Type in 2015
Figure Biologics Picture
Figure Biosimilars Picture
Table Application of Biologics and Biosimilars
Figure United States Sales Market Share of Biologics and Biosimilars by Application in 2015
Figure Tumor Examples
Figure Diabetes Examples
Figure Cardiovascular Examples
Figure Others Examples
Figure United States Biologics and Biosimilars Sales and Growth Rate (2011-2021)
Figure United States Biologics and Biosimilars Revenue and Growth Rate (2011-2021)
Table United States Biologics and Biosimilars Sales of Key Manufacturers (2015 and 2016)
Table United States Biologics and Biosimilars Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Biologics and Biosimilars Sales Share by Manufacturers
Figure 2016 Biologics and Biosimilars Sales Share by Manufacturers
Table United States Biologics and Biosimilars Revenue by Manufacturers (2015 and 2016)
Table United States Biologics and Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Biologics and Biosimilars Revenue Share by Manufacturers
Table 2016 United States Biologics and Biosimilars Revenue Share by Manufacturers
Table United States Market Biologics and Biosimilars Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Biologics and Biosimilars Average Price of Key Manufacturers in 2015
Figure Biologics and Biosimilars Market Share of Top 3 Manufacturers
Figure Biologics and Biosimilars Market Share of Top 5 Manufacturers
Table United States Biologics and Biosimilars Sales by Type (2011-2016)
Table United States Biologics and Biosimilars Sales Share by Type (2011-2016)
Figure United States Biologics and Biosimilars Sales Market Share by Type in 2015
Table United States Biologics and Biosimilars Revenue and Market Share by Type (2011-2016)
Table United States Biologics and Biosimilars Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Biologics and Biosimilars by Type (2011-2016)
Table United States Biologics and Biosimilars Price by Type (2011-2016)
Figure United States Biologics and Biosimilars Sales Growth Rate by Type (2011-2016)
Table United States Biologics and Biosimilars Sales by Application (2011-2016)
Table United States Biologics and Biosimilars Sales Market Share by Application (2011-2016)
Figure United States Biologics and Biosimilars Sales Market Share by Application in 2015
Table United States Biologics and Biosimilars Sales Growth Rate by Application (2011-2016)
Figure United States Biologics and Biosimilars Sales Growth Rate by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Biologics and Biosimilars Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Biologics and Biosimilars Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Biologics and Biosimilars Sales Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie Biologics and Biosimilars Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Biologics and Biosimilars Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Biologics and Biosimilars Sales Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novo Nordisk Biologics and Biosimilars Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Biologics and Biosimilars Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics and Biosimilars
Figure Manufacturing Process Analysis of Biologics and Biosimilars
Figure Biologics and Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
Table Major Buyers of Biologics and Biosimilars
Table Distributors/Traders List
Figure United States Biologics and Biosimilars Production and Growth Rate Forecast (2016-2021)
Figure United States Biologics and Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Table United States Biologics and Biosimilars Production Forecast by Type (2016-2021)
Table United States Biologics and Biosimilars Consumption Forecast by Application (2016-2021)
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Cell Sorting Market 2017 Forecast to 2022
    Published: 23-Jan-2018        Price: US 4880 Onwards        Pages: 122
    Cell sorting is the ability to separate cells according to their properties. These properties can be described as intracellular (inside the cell) or extracellular (outside the cell). Intracellular processes can include DNA, RNA and protein molecule interaction, whereas extracellular physical properties include size, shape (morphology), and surface protein expression. This report mainly studies the cell sorter market. Scope of the Report: This report focuses on the Cell Sort......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Urokinase Market 2017 Forecast to 2022
    Published: 23-Jan-2018        Price: US 4880 Onwards        Pages: 124
    Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin. ......
  • 2017 Top 5 Vegetable (HPMC) Capsule Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 23-Jan-2018        Price: US 4960 Onwards        Pages: 110
    "This report will be delivered in 2-3 business days after the order is placed." The Global Vegetable (HPMC) Capsule market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) of XX% from between 2016 and 2022. This report studies the global Vegetable (HPMC) Capsule market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 Vege......
  • United States Flu Vaccine Market by Manufacturers, States, Type and Application, Forecast to 2022
    Published: 23-Jan-2018        Price: US 4480 Onwards        Pages: 122
    Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them. Scope of the Report: Th......
  • 2017-2022 Asia-Pacific Top Countries Vegetable (HPMC) Capsule Market Report
    Published: 23-Jan-2018        Price: US 4660 Onwards        Pages: 110
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the Asia-Pacific Vegetable (HPMC) Capsule market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Vegetable (HPMC) Capsule in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, India, Australia, Indonesia, Thailand and Philippines, focuses on the top players in each count......
  • 2017-2022 China Vegetable (HPMC) Capsule Market Report (Status and Outlook)
    Published: 23-Jan-2018        Price: US 3360 Onwards        Pages: 110
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the Vegetable (HPMC) Capsule market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, the top players include - Capsugel - ACG Associated Capsules - Qualicaps - Shanxi GS Capsule - CapsCanada - Suheung Capsule - Qingdao Capsule - Lefa......
  • 2017-2022 Europe Top Countries Vegetable (HPMC) Capsule Market Report
    Published: 23-Jan-2018        Price: US 4660 Onwards        Pages: 110
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the Europe Vegetable (HPMC) Capsule market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Vegetable (HPMC) Capsule in Europe market, especially in Germany, UK, France, Italy, Russia, Benelux, Turkey and other countries in Europe, focuses on the top players in each country, covering......
  • 2017-2022 Global Top Countries Vegetable (HPMC) Capsule Market Report
    Published: 23-Jan-2018        Price: US 4960 Onwards        Pages: 110
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the global Vegetable (HPMC) Capsule market size was xx million USD, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Vegetable (HPMC) Capsule in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle E......
  • 2017-2022 India Vegetable (HPMC) Capsule Market Report (Status and Outlook)
    Published: 23-Jan-2018        Price: US 3360 Onwards        Pages: 110
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the Vegetable (HPMC) Capsule market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In India market, the top players include - Capsugel - ACG Associated Capsules - Qualicaps - Shanxi GS Capsule - CapsCanada - Suheung Capsule - Qingdao Capsule......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs